The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.

Biophotonic composition for the treatment of otitis external

Cerquetella, Matteo;Tambella, Adolfo Maria;Spaterna, Andrea;
2020-01-01

Abstract

The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
2020
285
File in questo prodotto:
File Dimensione Formato  
patent US20200230101.pdf

accesso aperto

Tipologia: Altro materiale allegato
Licenza: DRM non definito
Dimensione 783.06 kB
Formato Adobe PDF
783.06 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/445961
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact